Compare STRT & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | STRT | AMRN |
|---|---|---|
| Founded | 1908 | 1989 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Auto Parts:O.E.M. | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 322.9M | 339.8M |
| IPO Year | 1995 | 1993 |
| Metric | STRT | AMRN |
|---|---|---|
| Price | $75.43 | $13.71 |
| Analyst Decision | | Strong Sell |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $12.00 |
| AVG Volume (30 Days) | 53.7K | ★ 94.8K |
| Earning Date | 02-05-2026 | 10-29-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 45.55 | N/A |
| EPS | ★ 5.73 | N/A |
| Revenue | ★ $578,413,000.00 | $226,733,000.00 |
| Revenue This Year | $4.15 | N/A |
| Revenue Next Year | $4.12 | N/A |
| P/E Ratio | $13.28 | ★ N/A |
| Revenue Growth | ★ 6.83 | N/A |
| 52 Week Low | $31.57 | $7.08 |
| 52 Week High | $83.26 | $20.90 |
| Indicator | STRT | AMRN |
|---|---|---|
| Relative Strength Index (RSI) | 45.43 | 39.25 |
| Support Level | $79.29 | $13.48 |
| Resistance Level | $82.37 | $14.49 |
| Average True Range (ATR) | 2.66 | 0.64 |
| MACD | -0.96 | 0.06 |
| Stochastic Oscillator | 15.35 | 24.66 |
Strattec Security Corp designs develops, manufactures, and markets mechanical locks, electronically enhanced locks, and keys. It also produces ignition lock housings; and access control products, including latches, power sliding door systems, and door handles. Strattec ships products to customer locations in the United States, Canada, Mexico, Europe, South America, Korea, and China, and provides full-service aftermarket support. Strattec also supplies products for the heavy truck and recreational vehicle markets, as well as precision, die castings.
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.